摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(3S)-3-amino-2-oxo-1-phenylhexahydropipyridine hydrochloride | 672883-87-3

中文名称
——
中文别名
——
英文名称
(3S)-3-amino-2-oxo-1-phenylhexahydropipyridine hydrochloride
英文别名
(S)-3-amino-1-phenylpiperidin-2-one monohydrochloride;(S)-3-Amino-1-phenylpiperidin-2-one mono hydrochloride;(3S)-3-amino-1-phenylpiperidin-2-one;hydrochloride
(3S)-3-amino-2-oxo-1-phenylhexahydropipyridine hydrochloride化学式
CAS
672883-87-3
化学式
C11H14N2O*ClH
mdl
——
分子量
226.706
InChiKey
IWTUWXXJXXEFEI-PPHPATTJSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.56
  • 重原子数:
    15
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.36
  • 拓扑面积:
    46.3
  • 氢给体数:
    2
  • 氢受体数:
    2

反应信息

点击查看最新优质反应信息

文献信息

  • SUBSTITUTED ADIPIC ACID AMIDES AND USES THEREOF
    申请人:Sun Chongqing
    公开号:US20130345123A1
    公开(公告)日:2013-12-26
    The present invention provides compounds of Formula (I), or a pharmaceutically acceptable salt thereof, wherein A is a five to eight membered monocyclic or a nine to twelve membered bicyclic heterocyclic ring, as further defined herein; Y is S, CH 2 , or CH; Z is CH or N; R 7 and R 9 are hydrogen or (C 1 -C 6 )alkyl; R 2 is (C 1 -C 6 )alkoxy, OH, CN, (C 1 -C 6 )alkyl, halogen, or CF 3 ; r and s are 0, 1, or 2; and R 1 and R 3 are as further defined herein. These compounds are agonists, partial agonists and/or modulators of the NPY4 receptor and may be used for the treatment and prophylaxis of obesity, food intake, and other diseases and conditions modulated by the NPY4 receptor.
    本发明提供了式(I)的化合物或其药学上可接受的盐,其中A是进一步定义的五至八元杂环或九至十二元双环杂环;Y是S,CH2或CH;Z是CH或N;R7和R9是氢或(C1-C6)烷基;R2是(C1-C6)烷氧基,羟基,氰基,(C1-C6)烷基,卤素或CF3;r和s为0、1或2;而R1和R3的定义进一步如下。这些化合物是NPY4受体的激动剂、部分激动剂和/或调节剂,可用于治疗和预防肥胖、食物摄入和其他受NPY4受体调节的疾病和状况。
  • Substituted adipic acid amides and uses thereof
    申请人:Sun Chongqing
    公开号:US09346852B2
    公开(公告)日:2016-05-24
    The present invention provides compounds of Formula (I), or a pharmaceutically acceptable salt thereof, wherein A is a five to eight membered monocyclic or a nine to twelve membered bicyclic heterocyclic ring, as further defined herein; Y is S, CH2, or CH; Z is CH or N; R7 and R9 are hydrogen or (C1-C6)alkyl; R2 is (C1-C6)alkoxy, OH, CN, (C1-C6)alkyl, halogen, or CF3; r and s are 0, 1, or 2; and R1 and R3 are as further defined herein. These compounds are agonists, partial agonists and/or modulators of the NPY4 receptor and may be used for the treatment and prophylaxis of obesity, food intake, and other diseases and conditions modulated by the NPY4 receptor.
    本发明提供了公式(I)的化合物或其药学上可接受的盐,其中A是进一步定义的五至八元的单环或九至十二元的双环杂环环,Y是S,CH2或CH; Z是CH或N; R7和R9是氢或(C1-C6)烷基; R2是(C1-C6)烷氧基,羟基,氰基,(C1-C6)烷基,卤素或CF3; r和s为0,1或2; R1和R3如进一步定义。这些化合物是NPY4受体的激动剂,部分激动剂和/或调节剂,可用于治疗和预防肥胖,食物摄入和其他受NPY4受体调节的疾病和状况。
  • [EN] SUBSTITUTED ADIPIC ACID AMIDES AND USES THEREOF<br/>[FR] AMIDES DE L'ACIDE ADIPIQUE SUBSTITUÉS ET LEURS UTILISATIONS
    申请人:BRISTOL MYERS SQUIBB CO
    公开号:WO2012125622A1
    公开(公告)日:2012-09-20
    The present invention provides compounds of Formula (I), or a pharmaceutically acceptable salt thereof, wherein A is a five to eight membered monocyclic or a nine to twelve membered bicyclic heterocyclic ring, as further defined herein; Y is S, CH2, or CH; Z is CH or N; R7 and R9 are hydrogen or (C1-C6)alkyl; R2 is (C1 C6)alkoxy, OH, CN, (C1-C6)alkyl, halogen, or CF3; r and s are 0, 1, or 2; and R1 and R3 are as further defined herein. These compounds are agonists, partial agonists and/or modulators of the NPY4 receptor and may be used for the treatment and prophylaxis of obesity, food intake, and other diseases and conditions modulated by the NPY4 receptor.
    本发明提供了式(I)的化合物或其药学上可接受的盐,其中A是一个五至八元的单环或一个九至十二元的双环杂环环,如本文所进一步定义;Y是S、CH2或CH;Z是CH或N;R7和R9是氢或(C1-C6)烷基;R2是(C1-C6)烷氧基、羟基、氰基、(C1-C6)烷基、卤素或三氟甲基;r和s为0、1或2;R1和R3如本文所进一步定义。这些化合物是NPY4受体的激动剂、部分激动剂和/或调节剂,可用于治疗和预防肥胖、食物摄入和其他由NPY4受体调节的疾病和症状。
  • [EN] NEW HETEROCYCLIC AMIDE COMPOUNDS USEFUL FOR THE TREATMENT OF INFLAMMATORY AND ALLERGIC DISORDERS: PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM<br/>[FR] NOUVEAUX COMPOSES AMIDES HETEROCYCLIQUES UTILISES POUR LE TRAITEMENT D'AFFECTIONS INFLAMMATOIRES ET ALLERGIQUES; PROCEDE PERMETTANT DE LES FABRIQUER ET COMPOSITIONS PHARMACEUTIQUES LES CONTENANT
    申请人:GLENMARK PHARMACEUTICALS LTD
    公开号:WO2004022536A1
    公开(公告)日:2004-03-18
    The present invention relates to novel heterocyclic compounds that inhibit phosphodiesterase type 4 (PDE 4). The compounds are useful for treating inflammatory conditions, diseases of the central nervous systems and insulin resistant diabetes.
    本发明涉及一种新型杂环化合物,可抑制磷酸二酯酶4型(PDE 4)。这些化合物可用于治疗炎症性疾病、中枢神经系统疾病和胰岛素抵抗性糖尿病。
查看更多